CIRM Board Chairman Vito Imbasciani, with interim president Jonathan Thomas, photo courtesy of CIRMThe former chairman of the California stem cell agency is back on the job with the $12 billion agency – this time as its interim president while a search proceeds for a permanent chief executive officer.
A recent demonstration in support of curtailing drug prices. (Photo: California Nurses Association)OPINION: The best argument for passing Proposition 61 to cut drug prices in California, may be SB 1010, a modest effort to require the drug manufacturers give more notice and some justification when jacking up prices. Though the bill would not have actually cut prices, it drew ferocious opposition from a who’s who list of major pharmaceutical firms. They won.